Voting will close on December 21.

From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect

The problem finding eligible patients for oncology clinical trials – and the tech-driven solution

The importance of collaborative efforts in generating new vaccines to protect a vulnerable world

In the face of economic uncertainty in a post-pandemic world, how will the cell and gene field respond?

It’s December – time for The Medicine Maker to welcome you to 2022’s most innovative new technologies in drug development and manufacturing

Sitting Down With… Gen Li, CEO, Phesi

This free eBook showcases some of our top content covering outsourcing and supply chains.

A year of turmoil, and a year of change – just how healthy are pharma and the life sciences?

We all know that automation can reduce human labor, but how else can it make economically viable cell and gene therapies a reality?